Turner Syndrome and Fertility Issues
Published on: December 31, 2024
turner syndrome and fertility issues featured image

Introduction

Turner Syndrome, also known as congenital ovarian hypoplasia syndrome is a chromosomal disorder affecting only females. It is characterised by the partial or complete absence of one of the two X chromosomes. It was initially identified by Henry Hubert Turner in 1938 and is now recognised as the most common chromosomal disorder in females.1,2

Generally, females have a chromosomal pattern or karyotype (KAYR-ee-oh-ty-pe) of 46, XX. Still, in Turner Syndrome, this pattern changes to either a 45, X configuration, where one X chromosome is missing, or a mosaic pattern, where some cells have the usual two X chromosomes while others have only one.3

This genetic alteration impacts approximately 1 in every 2,000 to 2,500 live female births.1 Diagnosis typically occurs in early childhood or adolescence often prompted by a range of physical and developmental symptoms that necessitate genetic testing.1

The syndrome manifests through a range of physical and medical challenges, most notably short stature and premature ovarian failure, which leads to infertility and lack of spontaneous pubertal development without medical intervention. 

Management of the syndrome typically involves a combination of growth hormone therapy to address growth deficiencies and hormone replacement therapy to promote sexual development. There is no known cure. Despite these challenges, with appropriate medical care and monitoring, individuals with Turner Syndrome can lead full and productive lives.

Understanding Turner’s syndrome

Genetic characteristics 

Turner syndrome is characterised by unique genetic traits related to the X chromosome. Here are the main genetic features linked to this condition: 

Karyotype variations

  • 45,X karyotype: The most common genetic trait in Turner syndrome is having only one X chromosome without a matching X or Y chromosome, leading to a 45, X karyotype. This is present in around half of Turner syndrome cases6
  • Mosaicism: Some individuals may exhibit a mix of cells with 46 chromosomes (usually 46,XX) and cells with 45,X. This condition, known as mosaicism, can result in a milder form of the syndrome depending on the percentage of affected cells3
  • Abnormalities in the structure of the X chromosome: In some cases of Turner syndrome, individuals may have two X chromosomes, but one of them could have structural abnormalities like isochromosomes (chromosomes with identical arms), ring chromosomes, or deletions. These changes in the chromosome structure can impact the number of genes and contribute to the characteristics of Turner syndrome7,8

Gene dosage and escape from X-inactivation 

  • SHOX Gene: Short stature, often seen in Turner syndrome, is partially caused by the SHOX gene's abnormality known as haploinsufficiency. This gene, found on both the X and Y chromosomes, is important for bone growth and development and is able to escape X-inactivation
  • X-Inactivation: Typically, one of the two X chromosomes in females, one X chromosome is inactivated to ensure a balance in the dosage of X-linked genes between males and females. However, in Turner syndrome, where there is only one X chromosome present, there is no additional X chromosome to undergo inactivation which affects gene expression

Genetic implications

The absence or alteration of the X chromosome can impact various developmental pathways and organ systems, resulting in a range of clinical manifestations in Turner syndrome such as cardiovascular issues, kidney abnormalities, and hormonal problems like ovarian failure.

The presentation of Turner syndrome can vary widely depending on the specific genetic factors involved, whether it is complete monosomy, mosaicism, or structural anomalies. The symptoms of Turner syndrome can vary greatly among those affected, and the management approaches may also differ.5,7

Physical manifestations

Turner syndrome is a condition with distinct physical characteristics that may differ in severity based on an individual's chromosomal composition.9 These are the main physical traits often linked to Turner syndrome: 

Height 

Short stature is a common trait of Turner syndrome. Growth delays may be apparent during childhood, and without growth hormone therapy, adults with Turner syndrome may end up shorter than average. 

Lymphoedema 

Swelling in the hands and feet, usually noticeable from birth as puffiness, is caused by lymphoedema due to inadequate lymphatic drainage.8

Skeletal abnormalities 

Common skeletal features include a broad chest with widely spaced nipples, a low hairline at the back of the neck, and a short neck with excess skin folds. Additionally, affected individuals might have a high-arched palate, scoliosis, and malformed bones, particularly in the wrists and elbows.1

Cardiovascular anomalies 

Congenital heart defects such as bicuspid aortic valve and coarctation of the aorta are prevalent among those with Turner syndrome, increasing the risk of other cardiovascular complications later in life. 

Reproductive features 

Gonadal dysgenesis, which is the improper development of the ovaries, is common and often leads to primary amenorrhoea (lack of menstruation) and infertility in most females. 

Facial features 

Unique facial characteristics may consist of a fairly flat nose bridge and a mouth that turns downward.

Kidney abnormalities 

Approximately one-third of individuals with Turner syndrome may have abnormal kidney shape or position, leading to a higher risk of urinary tract infections and other renal complications. 

Hormonal imbalances

Individuals with Turner syndrome are at a greater risk of developing hypothyroidism, particularly of autoimmune origin such as Hashimoto’s thyroiditis. Additionally, conditions like diabetes and other metabolic disorders may be more common in this population.9,10

Diagnosis

Diagnosing Turner syndrome usually requires a mix of clinical assessment and genetic testing because of the unique physical traits and chromosomal issues linked to the condition. 

Clinical assessment 

  • Physical Indicators: Doctors initially think about Turner syndrome if there are telltale physical signs like short stature, lymphedema, distinct facial characteristics, and a broad chest with nipples spaced far apart 
  • Health background: Slow growth, absence of puberty development, and a background of specific heart problems may lead to more exploration

Karyotype analysis

Turner syndrome is definitively diagnosed through karyotyping, which examines the number and structure of chromosomes in cells. This test can identify if there is a complete or partial absence of one X chromosome or any other abnormalities like mosaicism. A blood sample is usually taken for this test, where cells are cultured, and their chromosomes stained and visualised under a microscope. 

Foetal diagnosis

  • Prenatal screening: Turner syndrome can sometimes be suspected during prenatal screening due to abnormal findings on ultrasound, such as a thickened nuchal fold, cystic hygroma, or congenital heart defects 
  • Prenatal testing: Chromosomal analysis using amniocentesis can also help in diagnosing Turner syndrome before birth
  • Further genetic testing: In cases where a regular karyotype shows no abnormalities but there is still concern based on physical and developmental indicators, more advanced genetic tests like fluorescence in situ hybridisation (FISH) or CGH (comparative genomic hybridisation) may be used. These tests can uncover more subtle chromosomal alterations that could be overlooked by a standard karyotype

Fertility challenges in Turner syndrome 

Challenges with fertility in Turner syndrome mainly occur because of issues with the ovaries that are present from birth.4 These issues are caused by the genetic abnormalities that are common in this syndrome. Let's take a closer look at how these challenges are influenced: 

  • Gonadal dysgenesis: This is the main reason for fertility problems. In Turner syndrome, the ovaries don't develop properly because of missing X chromosomes.6 Initially, the ovaries start as normal foetal gonads, but they quickly break down and become streak gonads – fibrous tissue without any germ cells. With streak gonads, there are no eggs available for potential fertilisation11
  • Premature ovarian failure (POF): Turner syndrome can cause girls to have a small number of oocytes at birth, but they are typically lost quickly.12 This rapid loss often results in premature ovarian failure before puberty, although some girls may experience puberty naturally and even have rare spontaneous pregnancies
  • Y Chromosome material and gonadoblastoma: In Turner syndrome cases with mosaicism and Y chromosome material present, there is a higher risk of developing gonadoblastoma, a type of tumour in the gonads.13 This necessitates the preventive removal of the gonads, which can impact fertility

Clinically, over 90% of women with Turner syndrome are infertile. While infertility rates are generally high, there can be some variation based on individual chromosomal differences. People with classic Turner syndrome (45,X) usually have their ovaries stop functioning early in life. In some cases of mosaicism, where some cells have a full set of chromosomes (e.g., 46,XX or 45,X/46,XX), there may be some ovarian function.4 

In very rare cases, this could lead to spontaneous menstruation or even fertility. However, even in mosaic cases, fertility issues are common. Spontaneous pregnancy in Turner syndrome is extremely rare, with only about 2-5% of individuals with the condition experiencing it, usually those with a mosaic karyotype. These pregnancies are often complicated and come with high risks such as hypertension, aortic dissection, and preterm labour.14,15

Impact of infertility on physical health and psychological well-being

The impact of infertility in individuals with Turner syndrome is significant, affecting both their physical health and psychological well-being.17 The consequences are wide-ranging:

Physical health effects 

  • Hormonal imbalances: Infertility in Turner syndrome is often attributed to ovarian insufficiency, resulting in low levels of sex hormones, particularly oestrogen. This can cause delayed puberty and impact the development of secondary sexual characteristics
  • Increased risk of osteoporosis: Oestrogen is crucial for maintaining bone density
  • Reduced oestrogen levels raise the risk of osteoporosis and bone fractures
  • Cardiovascular health: Oestrogen plays a protective role in heart health, so its deficiency can have negative effects on cardiovascular well-being 

Psychological and emotional well-being 

  • Challenges with self-identity: The changes in the body caused by hormones during the development of secondary sexual characteristics may impact how individuals perceive themselves and their self-worth. People with Turner syndrome may find it difficult to fit in with their peers, especially during their teenage years 
  • Struggles with loss: Coping with the inability to conceive can trigger feelings of grief and loss, especially as individuals with Turner syndrome grow older and realise their reproductive limitations compared to others their age. This can be an ongoing source of sadness or feelings of deep sadness 
  • Anxiety and depression: Worries about their personal health, fertility, and how others view them can contribute to higher rates of anxiety and depression among women with Turner syndrome17

When facing infertility, individuals may experience difficulties in personal relationships and social interactions. This can lead to feelings of isolation and disconnection from peers, particularly in societies that place a strong emphasis on starting a family. In addition to this, dealing with Turner syndrome involves frequent medical check-ups, various treatments, and managing multiple health problems. This can take a toll on a person's mental well-being and add to the ongoing stress they may be experiencing.

Management of fertility issues

Dealing with fertility problems in Turner syndrome requires attention to the intricate connections between genetics, medicine, and mental well-being. With a high prevalence of gonadal dysgenesis leading to infertility, the main goal of treatment and care is to offer holistic support to those affected.16,18 Presented below are important considerations in handling fertility issues in Turner syndrome:

Hormone replacement therapy (HRT) 

Oestrogen and progesterone: Since most individuals with Turner syndrome do not produce sufficient natural oestrogen, hormone replacement therapy is typically started around the age of puberty to initiate and maintain secondary sexual characteristics, such as breast development and uterine growth. 

Timing and Dosage: The initiation and dosage of HRT should be carefully managed to mimic natural puberty, usually beginning with a low dose of estrogen that is gradually increased over time. 

Fertility counseling 

  • Early and ongoing counselling: Providing information about the fertility issues associated with Turner syndrome is crucial. Counselling can help patients and their families understand the options available, including the use of assisted reproductive technologies (ART)
  • Emotional support: Discussing infertility can be emotionally challenging. Support from psychologists or specialised counsellors can help individuals cope with the psychological aspects of Turner syndrome

Assisted reproductive technologies (ART) 

IVF with donor eggs: For those desiring to conceive, IVF using donor eggs is the most common method. The woman’s uterus in Turner syndrome is generally capable of sustaining a pregnancy if hormonally prepared, even if her eggs are not viable.18 

Surrogacy and adoption

These are also viable options for family building that can be explored depending on individual preferences and how medical health is addressed, particularly when considering pregnancy. Management of fertility issues in Turner syndrome requires a holistic approach tailored to each individual's circumstances, balancing the desire for children with the health risks associated with pregnancy in this condition.

Summary

Turner syndrome poses distinctive and intricate hurdles in terms of fertility, originating from chromosomal irregularities that impact the growth of ovaries. The vast majority of those with Turner syndrome face challenges with fertility due to issues like gonadal dysgenesis and early ovarian dysfunction. 

Nevertheless, progress in the field of medicine and fertility interventions brings optimism and potential. Hormone replacement therapy is essential for kick-starting and sustaining sexual development, ultimately playing a vital part in upholding general health and wellness. Looking to start a family, there are several routes you can take such as IVF using donor eggs, surrogacy, or adoption. People exploring these options must receive thorough counselling so they can fully grasp the pros and cons. 

Additionally, managing Turner syndrome and its effects on fertility calls for a team effort from specialists in endocrinology, gynaecology, fertility, genetics, and cardiology. With appropriate medical care, psychological support, and access to fertility resources, women with Turner syndrome can lead fulfilling lives and explore various avenues to pursue parenthood, should they choose to do so.

The journey is complex and fraught with medical challenges, but with the right support and management, the aspirations for family life can often be realised in a meaningful way.

References 

  1. Shankar Kikkeri N, Nagalli S. Turner Syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Apr 12]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK554621/.
  2. Elsheikh M, Dunger DB, Conway GS, Wass JAH. Turner’s Syndrome in Adulthood. Endocrine Reviews [Internet]. 2002 [cited 2024 Apr 12]; 23(1):120–40. Available from: https://academic.oup.com/edrv/article/23/1/120/2424315.
  3. Zhong Q, Layman LC. Genetic Considerations in the Patient with Turner Syndrome—45,X with or without Mosaicism. Fertil Steril [Internet]. 2012 [cited 2024 Apr 12]; 98(4):775–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573687/.
  4. Viuff M, Gravholt CH. Turner Syndrome and Fertility. Annales d’Endocrinologie [Internet]. 2022 [cited 2024 Apr 12]; 83(4):244–9. Available from: https://www.sciencedirect.com/science/article/pii/S0003426622000907.
  5. Fudge EB. Turner syndrome: narrative review of genetics and clinical aspects of management. Pediatric Medicine [Internet]. 2024 [cited 2024 Apr 12]; 7(0). Available from: https://pm.amegroups.org/article/view/7267.
  6. Dunkel L. Delayed Puberty and Hypogonadism, Female. In: Encyclopedia of Endocrine Diseases [Internet]. Elsevier; 2004 [cited 2024 Apr 12]; p. 615–21. Available from: https://linkinghub.elsevier.com/retrieve/pii/B0124755704003681.
  7. Ferdousi T, Banu H, Sultana N, Mahrukh H, Hasanat MA. Turner Syndrome With Isochromosome Structural Abnormalities: A Case Report. Cureus [Internet]. [cited 2024 Apr 12]; 15(6):e40516. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350310/.
  8. Mazzocco MMM, Quintero AI, Murphy MM, McCloskey M. Chapter 12 - Genetic Syndromes as Model Pathways to Mathematical Learning Difficulties: Fragile X, Turner, and 22q Deletion Syndromes. In: Berch DB, Geary DC, Koepke KM, editors. Development of Mathematical Cognition [Internet]. San Diego: Academic Press; 2016 [cited 2024 Apr 12]; p. 325–57. Available from: https://www.sciencedirect.com/science/article/pii/B9780128018712000125.
  9. Acosta AM, Steinman SE, White KK. Orthopaedic Manifestations in Turner Syndrome. J Am Acad Orthop Surg [Internet]. 2019 [cited 2024 Apr 12]; 27(23):e1021–8. Available from: https://journals.lww.com/10.5435/JAAOS-D-17-00796.
  10. El-Mansoury M, Bryman I, Berntorp K, Hanson C, Wilhelmsen L, Landin-Wilhelmsen K. Hypothyroidism Is Common in Turner Syndrome: Results of a Five-Year Follow-Up. The Journal of Clinical Endocrinology & Metabolism [Internet]. 2005 [cited 2024 Apr 12]; 90(4):2131–5. Available from: https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2004-1262.
  11. Clemente EG, Maravol PV, Tanager CL. Gonadal dysgenesis: a clinical overview of Turner syndrome. Pediatric Medicine [Internet]. 2019 [cited 2024 Apr 12]; 2(0). Available from: https://pm.amegroups.org/article/view/4930.
  12. Fukami M. Ovarian dysfunction in women with Turner syndrome. Front Endocrinol (Lausanne) [Internet]. 2023 [cited 2024 Apr 12]; 14:1160258. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076527/.
  13. Gravholt CH, Fedder J, Naeraa RW, Müller J. Occurrence of Gonadoblastoma in Females with Turner Syndrome and Y Chromosome Material: A Population Study*. The Journal of Clinical Endocrinology & Metabolism [Internet]. 2000 [cited 2024 Apr 12]; 85(9):3199–202. Available from: https://academic.oup.com/jcem/article/85/9/3199/2660561.
  14. Hewitt JK, Jayasinghe Y, Amor DJ, Gillam LH, Warne GL, Grover S, et al. Fertility in Turner syndrome. Clinical Endocrinology [Internet]. 2013 [cited 2024 Apr 12]; 79(5):606–14. Available from: https://onlinelibrary.wiley.com/doi/10.1111/cen.12288.
  15. Abir R, Oron G, Shufaro Y. Fertility in patients with Turner syndrome. Fertility and Sterility [Internet]. 2020 [cited 2024 Apr 12]; 114(1):73–4. Available from: https://linkinghub.elsevier.com/retrieve/pii/S001502822030337X.
  16. Cauldwell M, Steer P, Adamson D, Alexander C, Allen L, Bhagra C, et al. Pregnancies in women with Turner syndrome: a retrospective multicentre UK study. BJOG [Internet]. 2022 [cited 2024 Apr 12]; 129(5):796–803. Available from: https://obgyn.onlinelibrary.wiley.com/doi/10.1111/1471-0528.17025.
  17. Gupta M, Zubiar F, Gupta N. Turner Syndrome and the Risks of Clinical Depression in Adolescence. Cureus [Internet]. [cited 2024 Apr 12]; 13(11):e19204. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638214/.
  18. Hovatta O. Ovarian function and in vitro fertilization (IVF) in Turner syndrome. Pediatr Endocrinol Rev. 2012; 9 Suppl 2:713–7.
Share

Agnes Majczak

Doctor of Dental Surgery, DDS Poznan University of Medical Sciences, Poland

Agnes is an Associate Dentist with a passion for clinical excellence and medical communication. Fluent in Polish, she has also translated numerous dental articles, enhancing access to critical research for a broader audience. She has several years experience working as a GDC registered Dentist.

arrow-right